Medical Devices Startups

NB Health Laboratory develops antibody therapeutics for drug discovery and development to address unmet medical needs in healthcare.

1 investor

N.B. Medical develops neurovascular medical devices combined with in-house regulation-integrated computational modeling and simulation (CMS), AI-driven documentation, and digital-twin technologies such as virtual stent deployment via a proprietary finite-element solver. Based in Japan, it aims to accelerate precise, regulation-ready medical device development.

1 investor

NC Biomatrix develops biologic therapies targeting musculoskeletal degeneration, with a lead product (VitaDisc) addressing intervertebral disc degeneration and chronic lower back pain, and ongoing research into osteoarthritis treatments for synovial joints.

1 investor

Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.

1 investor

Ncerebro (주식회사 엔서) develops medical and wellness devices, including near-infrared spectroscopy-based instruments for measuring blood oxygen saturation, olfactory-based screening for cognitive impairment, and brain wellness devices for sleep and stress. The company serves surgical and neurological healthcare use cases.

1 investor

ANT-C is an AI-powered system that uses CT-scan images to automate lesion detection, needle path planning, and needle targeting for interventional procedures. The system is compatible with all CT scanner types and applicable across pulmonology, hepatology, gastroenterology and other medical specialties.

1 investor

Nebuflow develops drug delivery technology for pharmaceutical applications. The company focuses on transforming how life-changing drugs are delivered.

1 investor

Nectero Therapeutics develops therapeutic medical devices with a focus on vascular medicine applications. The company is led by a team with extensive experience in regulatory affairs, product development, and quality assurance for medical device manufacturing.

1 investor

NELA Santé is a mobile healthcare service founded by nurses that brings laboratory services and personalized medical care to families and corporations in Montreal. The company specializes in convenient, at-home care delivery with a focus on gentle, professional service.

1 investor

Nelipak manufactures specialized packaging solutions for healthcare and life sciences companies. The company operates 14 manufacturing sites globally and serves pharmaceutical, medical device, and biotech customers with cleanroom-certified, safety-focused packaging products.

1 investor

NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.

1 investor

Neo-Bionica develops neurotechnology devices and systems, leveraging expertise in implantable device design, neural interfaces, and medical device engineering for the neurotech market.

1 investor

Neobiomics develops multi-strain food supplements rooted in academic research, with collaborations across Europe. The company is affiliated with Karolinska Institutet and focuses on bringing innovative, science-based nutritional products to market.

1 investor

NeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.

1 investor

Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.

1 investor

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

1 investor

NeoVac develops proprietary lipid technology for lipid nanoparticles (LNPs) designed to support mRNA-based therapeutics in vaccines, cancer immunotherapy, and autoimmune disease treatment. The company's lipid platform emphasizes tunable degradability to enhance safety and efficacy profiles.

1 investor

Nephrodi is a biotechnology company developing treatments for kidney conditions, including the rare disease Nephrogenic Diabetes Insipidus (NDI). Its work centers on renal physiology research and translating it toward clinical products.

1 investor

Nephrolyx develops the IVDx system, combining an IVD kit with GFRx software that integrates into laboratory LIMS to measure glomerular filtration rate (mGFR) via iohexol plasma clearance for kidney function diagnostics in clinical routine. It serves physicians, clinical laboratories, and pharma/biotech companies conducting kidney research, and also offers the DNPx digital platform for research use.

1 investor

NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.

1 investor

Net-Targets applies AI-enhanced systems biology to identify drug targets and mechanisms for pharmaceutical development. The company combines biological experimentation, mathematical modeling, and computer simulation to uncover hidden biological networks that inform medicine development.

1 investor

Neucore Bio develops precision therapeutics using engineered exosomes derived from fibroblasts to deliver molecular-level cellular repair and renewal across genetic and degenerative diseases with high unmet medical needs.

1 investor

Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.

1 investor

NeurAbilities Healthcare provides diagnostic and therapeutic services for patients with neurological and developmental conditions, combining precision medicine, behavioral sciences, and therapeutic treatments. It serves patients seeking neurological and behavioral healthcare.

1 investor